A novel product labeled as “SottSunFeli Maximum strength wart remover patches” containing beta-cyclodextrin and 30% salicylic acid as active ingredient has been launched on 23 Nov, 2025 in the US as a human topical OTC drug. The producer is Henan Toudaorong Biotechnology Co., Ltd., China. The indication is treatment for common and plantar warts.

